Capital World Investors
GWPH

Capital World Investors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Capital World Investors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-280,774
Closed -$60.9M – 633
2021
Q1 		$60.9M Sell
280,774
-2,476,239
-90% -$465M 0.01% 415
2020
Q4 		$318M Buy
2,757,013
+2,369
+0.1% +$265K 0.06% 240
2020
Q3 		$268M Buy
2,754,644
+889,473
+48% +$102M 0.06% 243
2020
Q2 		$229M Buy
1,865,171
+725,207
+64% +$82.3M 0.06% 236
2020
Q1 		$99.8M Buy
1,139,964
+35,359
+3% +$3.74M 0.03% 276
2019
Q4 		$115M Buy
1,104,605
+159,491
+17% +$17.9M 0.03% 295
2019
Q3 		$109M Sell
945,114
-1,767,062
-65% -$268M 0.03% 288
2019
Q2 		$468M Buy
2,712,176
+602
+0% +$104K 0.11% 168
2019
Q1 		$457M Buy
2,711,574
+2
+0% +$298 0.11% 166
2018
Q4 		$264M Buy
2,711,572
+194,482
+8% +$25.5M 0.07% 203
2018
Q3 		$435M Buy
2,517,090
+335,840
+15% +$48.4M 0.11% 178
2018
Q2 		$304M Hold
2,181,250
– – 0.07% 205
2018
Q1 		$246M Buy
2,181,250
+745,371
+52% +$93.7M 0.06% 223
2017
Q4 		$190M Buy
1,435,879
+760,079
+112% +$89.3M 0.04% 241
2017
Q3 		$68.6M Hold
675,800
– – 0.02% 332
2017
Q2 		$67.7M Buy
675,800
+40,000
+6% +$4.3M 0.02% 327
2017
Q1 		$76.9M Hold
635,800
– – 0.02% 312
2016
Q4 		$71.1M Sell
635,800
-125,000
-16% -$15M 0.02% 312
2016
Q3 		$101M Buy
760,800
+323,700
+74% +$30.9M 0.03% 278
2016
Q2 		$40M Hold
437,100
– – 0.01% 355
2016
Q1 		$31.5M Hold
437,100
– – 0.01% 371
2015
Q4 		$30.4M Hold
437,100
– – 0.01% 388
2015
Q3 		$39.9M Hold
437,100
– – 0.01% 364
2015
Q2 		$53.7M Buy
437,100
+87,000
+25% +$9.87M 0.01% 363
2015
Q1 		$31.9M Buy
350,100
+140,100
+67% +$11.4M 0.01% 405
2014
Q4 		$14.2M Buy
+210,000
New +$15.3M ﹤0.01% 467

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Capital World Investors's GWPH Position: Q2 2021 in Review

Capital World Investors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 280,774 shares — an estimated $60.9M sold.

Capital World Investors first reported a position in GWPH in Q4 2014 and held it in 26 quarters. The position peaked at $468M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Capital World Investors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Capital World Investors sold 280,774 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $60.9M.
  • Capital World Investors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 26 quarters.
  • Capital World Investors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $468M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Capital World Investors's 13F filing for Q2 2021, filed 16 Aug 2021.